Windtree Therapeutics Inc

WINT

Exchange: OTC
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000946486

SEC filings (opens in a new tab)

No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Windtree Therapeutics Inc changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of WINT: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	26	27	+1
Shares	1.71M	1.54M	−169.0K (−9.9%)
Value	$2.72M	$1.76M	−$968.3K (−35.5%)

New holders (3)

Institutions that held Windtree Therapeutics Inc at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to WINT in Q1 2022
Institution	Shares	Value	% of portfolio
Envestnet Asset Management Inc	10,045	$11.0K	0.00%
Captrust Financial Advisors	1,500	$2.00K	0.00%
Banque Cantonale Vaudoise	1	$0	0.00%

Sold out (2)

Institutions that held Windtree Therapeutics Inc at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of WINT in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Citadel Advisors LLC	40,996	$66.0K
Dimensional Fund Advisors LP	12,906	$21.0K